ANTICOAGULANTS IN THERAPY OF PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION: WHICH DRUG TO BE CHOSEN?

Problem of anticoagulant choice in patients with acute coronary syndrome (ACS) is discussed. Results of the main trials on low-molecular heparin therapy in patients with ACS as well as recommendations of European cardiology society and American heart association are presented. Peculiarities of other...

Full description

Saved in:
Bibliographic Details
Main Authors: A. L. Komarov, E. P. Panchenko
Format: Article
Language:English
Published: Столичная издательская компания 2016-01-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:https://www.rpcardio.online/jour/article/view/1095
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849227779426484224
author A. L. Komarov
E. P. Panchenko
author_facet A. L. Komarov
E. P. Panchenko
author_sort A. L. Komarov
collection DOAJ
description Problem of anticoagulant choice in patients with acute coronary syndrome (ACS) is discussed. Results of the main trials on low-molecular heparin therapy in patients with ACS as well as recommendations of European cardiology society and American heart association are presented. Peculiarities of other therapies (thrombin inhibitors, Ха-factor inhibitors) in ACS are surveyed.
format Article
id doaj-art-342e4e08ddd84d18b4eb3ba69fda4dc1
institution Kabale University
issn 1819-6446
2225-3653
language English
publishDate 2016-01-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj-art-342e4e08ddd84d18b4eb3ba69fda4dc12025-08-23T10:00:25ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532016-01-0142667510.20996/1819-6446-2008-4-2-66-751094ANTICOAGULANTS IN THERAPY OF PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION: WHICH DRUG TO BE CHOSEN?A. L. Komarov0E. P. Panchenko1Institute of Cardiology named after A.L.Myasnikov, Russian Cardiological Research Complex of Rosmedtechnology, MoscowInstitute of Cardiology named after A.L.Myasnikov, Russian Cardiological Research Complex of Rosmedtechnology, MoscowProblem of anticoagulant choice in patients with acute coronary syndrome (ACS) is discussed. Results of the main trials on low-molecular heparin therapy in patients with ACS as well as recommendations of European cardiology society and American heart association are presented. Peculiarities of other therapies (thrombin inhibitors, Ха-factor inhibitors) in ACS are surveyed.https://www.rpcardio.online/jour/article/view/1095acute coronary syndromeanticoagulantslow-molecular heparins
spellingShingle A. L. Komarov
E. P. Panchenko
ANTICOAGULANTS IN THERAPY OF PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION: WHICH DRUG TO BE CHOSEN?
Рациональная фармакотерапия в кардиологии
acute coronary syndrome
anticoagulants
low-molecular heparins
title ANTICOAGULANTS IN THERAPY OF PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION: WHICH DRUG TO BE CHOSEN?
title_full ANTICOAGULANTS IN THERAPY OF PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION: WHICH DRUG TO BE CHOSEN?
title_fullStr ANTICOAGULANTS IN THERAPY OF PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION: WHICH DRUG TO BE CHOSEN?
title_full_unstemmed ANTICOAGULANTS IN THERAPY OF PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION: WHICH DRUG TO BE CHOSEN?
title_short ANTICOAGULANTS IN THERAPY OF PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION: WHICH DRUG TO BE CHOSEN?
title_sort anticoagulants in therapy of patients with acute coronary syndrome without st segment elevation which drug to be chosen
topic acute coronary syndrome
anticoagulants
low-molecular heparins
url https://www.rpcardio.online/jour/article/view/1095
work_keys_str_mv AT alkomarov anticoagulantsintherapyofpatientswithacutecoronarysyndromewithoutstsegmentelevationwhichdrugtobechosen
AT eppanchenko anticoagulantsintherapyofpatientswithacutecoronarysyndromewithoutstsegmentelevationwhichdrugtobechosen